Pletcher, A. & Shibata, M. Prostate organogenesis. Development 149, dev200394 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dai, C., Heemers, H. & Sharifi, N. Androgen signaling in prostate cancer. Cold Spring Harb. Perspect. Med. 7, a030452 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Watson, P. A., Arora, V. K. & Sawyers, C. L. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat. Rev. Cancer 15, 701–711 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clocchiatti, A., Cora, E., Zhang, Y. & Dotto, G. P. Sexual dimorphism in cancer. Nat. Rev. Cancer 16, 330–339 (2016).

Article  CAS  PubMed  Google Scholar 

Haupt, S., Caramia, F., Klein, S. L., Rubin, J. B. & Haupt, Y. Sex disparities matter in cancer development and therapy. Nat. Rev. Cancer 21, 393–407 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rubin, J. B. The spectrum of sex differences in cancer. Trends Cancer 8, 303–315 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dotto, G. P. Gender and sex-time to bridge the gap. EMBO Mol. Med. 11, e10668 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Davey, R. A. & Grossmann, M. Androgen receptor structure, function and biology: from bench to bedside. Clin. Biochem. Rev. 37, 3–15 (2016).

PubMed  PubMed Central  Google Scholar 

Heemers, H. V. & Tindall, D. J. Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr. Rev. 28, 778–808 (2007).

Article  CAS  PubMed  Google Scholar 

Kono, M. et al. Androgen receptor function and androgen receptor-targeted therapies in breast cancer: a review. JAMA Oncol. 3, 1266–1273 (2017).

Article  PubMed  Google Scholar 

Shukla, G. C., Plaga, A. R., Shankar, E. & Gupta, S. Androgen receptor-related diseases: what do we know? Andrology 4, 366–381 (2016).

Article  CAS  PubMed  Google Scholar 

Matsumoto, T. et al. The androgen receptor in health and disease. Annu. Rev. Physiol. 75, 201–224 (2013).

Article  CAS  PubMed  Google Scholar 

Liu, W.-J. et al. Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer. J. Cell. Biochem. 121, 2756–2769 (2020).

Article  CAS  PubMed  Google Scholar 

Leach, D. A., Fernandes, R. C. & Bevan, C. L. Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer. Endocr. Oncol. 2, R112–R131 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Dahiya, U. R. & Heemers, H. V. Analyzing the androgen receptor interactome in prostate cancer: implications for therapeutic intervention. Cells 11, 936 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Leung, J. K. & Sadar, M. D. Non-genomic actions of the androgen receptor in prostate cancer. Front. Endocrinol. 8, 2 (2017).

Article  Google Scholar 

Bennesch, M. A. & Picard, D. Minireview: tipping the balance: ligand-independent activation of steroid receptors. Mol. Endocrinol. 29, 349–363 (2015).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo, Z. et al. Regulation of androgen receptor activity by tyrosine phosphorylation. Cancer Cell 10, 309–319 (2006).

Article  CAS  PubMed  Google Scholar 

Ueda, T., Bruchovsky, N. & Sadar, M. D. Activation of the androgen receptor N-terminal domain by interleukin-6 via mAPK and STAT3 signal transduction pathways. J. Biol. Chem. 277, 7076–7085 (2002).

Article  CAS  PubMed  Google Scholar 

Cai, L. et al. ZFX mediates non-canonical oncogenic functions of the androgen receptor splice variant 7 in castrate-resistant prostate cancer. Mol. Cell 72, 341–354.e6 (2018).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dahiya, V. & Bagchi, G. Non-canonical androgen signaling pathways and implications in prostate cancer. Biochim. Biophys. Acta Mol. Cell Res. 1869, 119357 (2022).

Article  CAS  PubMed  Google Scholar 

Thomas, P. Membrane androgen receptors unrelated to nuclear steroid receptors. Endocrinology 160, 772–781 (2019).

Article  CAS  PubMed  Google Scholar 

Hughes, I. A. et al. Androgen insensitivity syndrome. Lancet 380, 1419–1428 (2012).

Article  CAS  PubMed  Google Scholar 

Turcu, A. F., Rege, J., Auchus, R. J. & Rainey, W. E. 11-oxygenated androgens in health and disease. Nat. Rev. Endocrinol. 16, 284–296 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marchetti, P. M. & Barth, J. H. Clinical biochemistry of dihydrotestosterone. Ann. Clin. Biochem. 50, 95–107 (2013).

Article  CAS  PubMed  Google Scholar 

Labrie, F. All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause. J. Steroid Biochem. Mol. Biol. 145, 133–138 (2015).

Article  CAS  PubMed  Google Scholar 

Pugeat, M. et al. Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome. Mol. Cell. Endocrinol. 316, 53–59 (2010).

Article  CAS  PubMed  Google Scholar 

Simó, R., Sáez-López, C., Barbosa-Desongles, A., Hernández, C. & Selva, D. M. Novel insights in SHBG regulation and clinical implications. Trends Endocrinol. Metab. 26, 376–383 (2015).

Article  PubMed  Google Scholar 

Samarkina, A. et al. Androgen receptor is a determinant of melanoma targeted drug resistance. Nat. Commun. 14, 6498 (2023). This study reveals that increased AR expression in melanoma cells is both required and sufficient to confer resistance to BRAF inhibitors through transcriptional activation mechanisms that can be targeted.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castoria, G. et al. Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J. Cell Biol. 161, 547–556 (2003).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Acharya, S. et al. Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer. J. Biol. Chem. 299, 102725 (2023).

Article  CAS  PubMed  Google Scholar 

Shao, C. et al. Biphasic effect of androgens on prostate cancer cells and its correlation with androgen receptor coactivator dopa decarboxylase. J. Androl. 28, 804–812 (2007).

Article